CARDURION PHARMACEUTICALS
Cardurion is a Boston-based cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. In July, 2017, Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new preclinical partnership to develop novel, next-generation therapeutics for the treatment of heart failure and cardiovascular diseases. The partnership with Cardurion follows Takeda’s strategy to leverage external innovation by... placing selected assets and outstanding scientists in an entrepreneurial setting and enables the Discovery programs of Cardurion. In April 2018, Cardurion announced the Company entered an exclusive licensing agreement with Astellas to develop and commercialize CRD-733, a PDE-9 inhibitor with the potential to improve cardiac function in heart failure patients. With recent evidence supporting that inhibition of PDE-9 has potential to restore heart-protective mechanisms that are dysfunctional in heart failure, CRD-733 has the potential to address the cell-signaling breakdown that contributes to the progression of heart failure.
CARDURION PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.cardurion.com
Total Employee:
11+
Status:
Active
Contact:
617-996-1433
Total Funding:
325.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Nginx
Similar Organizations
Cyagen Biosciences
Cyagen Biosciences is an emerging and innovative biotechnology company.
Dizal Pharma
Dizal Pharma is a research-based biotechnology company.
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Panacea Biotec
Panacea Biotec is an Innovation driven Biotechnology company.
Current Employees Featured
Marcia Moore Chief Operating Officer @ Cardurion Pharmaceuticals
Chief Operating Officer
2022-01-01
Michael Mendelsohn Founder & Chairman @ Cardurion Pharmaceuticals
Founder & Chairman
2016-05-01
Howard Surks Chief Medical Officer and Head of Translational Medicine @ Cardurion Pharmaceuticals
Chief Medical Officer and Head of Translational Medicine
2021-06-01
Founder
Investors List
Polaris Partners
Polaris Partners investment in Series B - Cardurion Pharmaceuticals
Bain Capital
Bain Capital investment in Series B - Cardurion Pharmaceuticals
Takeda
Takeda investment in Series B - Cardurion Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series A - Cardurion Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.cardurion.com Semrush global rank: 5.55 M Semrush visits lastest month: 1.53 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cardurion Pharmaceuticals"
About Cardurion - Cardurion
Cardurion is at the forefront of discovering desperately needed new approaches to treating heart disease. We were founded by physician-scientists who possess world-class expertise in cardiovascular signaling pathways, and we couple …See details»
Cardurion Pharmaceuticals - Crunchbase Company …
Cardurion Pharmaceuticals is a Boston-based biotechnology company focused on developing novel therapeutics for the treatment of heart failure and other cardiovascular diseases. The company is advancing groundbreaking clinical …See details»
Leadership - Cardurion
Leadership Cardurion was founded by physician-scientist Michael E. Mendelsohn, M.D., and built by a team of physician-scientists and industry leaders with extensive experience in …See details»
Cardurion Company Profile 2025: Valuation, Funding
Cardurion General Information Description. Developer of cardiovascular therapeutics intended to treat cardiovascular diseases. The company's therapeutics offer advanced novel mechanisms to develop new treatments for …See details»
Cardurion Pharmaceuticals - Overview, News & Similar companies ...
Apr 19, 2023 Cardurion Pharmaceuticals is a biotechnology company focused on the discovery and development of next-generation therapeutics for the treatment of heart failure and other …See details»
Cardurion Pharmaceuticals Company Profile | Management and
Cardurion Pharmaceuticals Profile and History. Cardurion Pharmaceuticals is a biotechnology company focused on the discovery and development of next-generation therapeutics for the …See details»
Cardurion Pharmaceuticals Overview | SignalHire Company Profile
Cardurion Pharmaceuticals is a private company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. …See details»
Cardurion Pharmaceuticals - Contacts, Employees, Board Members ...
Organization. Cardurion Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Cardurion …See details»
Cardurion Pharma - VentureRadar
" Cardurion, a Boston-based, clinical-stage cardiovascular biotechnology company, is developing novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular …See details»
Cardurion Pharmaceuticals - Funding, Financials, Valuation
Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases. ... How much funding has this organization raised …See details»
Cardurion Pharmaceuticals - Bain Capital Life Sciences
Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation therapeutics for the treatment of cardiovascular …See details»
Cardurion Pharmaceuticals - Craft
Cardurion Pharmaceuticals is a cardiovascular biotechnology company offering therapeutics for the treatment of heart failure and cardiovascular diseases. It develops and commercializes …See details»
Cardurion Pharmaceuticals Selected as an Endpoints 11 Most …
Sep 27, 2024 BURLINGTON, Mass., September 27, 2024--Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics …See details»
Cardurion Pharmaceuticals Enhances Leadership Team with …
Feb 17, 2022 Brings More Than 30 Years of Pharmaceutical and Biotechnology Leadership Experience Supports Cardurion’s Continued Advancement of Growing Pipeline of …See details»
Cardurion Management Team - CB Insights
Jeb is an independent director on the Boards of Cardurion Pharmaceuticals, a clinical-stage cardiovascular diseases company and Rome Therapeutics, an oncology-focused preclinical …See details»
Cardurion Pharmaceuticals - Work in biotech
Cardurion Pharmaceuticals is a next-generation cardiovascular biotech company founded by Dr. Michael E. Mendelsohn, a physician-Scientist with over 150 published articles. They focus on …See details»
Careers and Culture - Cardurion
Careers and Culture Turn Your Passion Into Impact at Cardurion Cardurion’s company culture centers on fundamental values. We prioritize the needs of patients with cardiovascular disease …See details»
JPMorgan and BlackRock C-suite departure surprises show why
1 day ago Getting on the CEO successor shortlist could bring opportunities on its own, expert says.See details»
Research and Development - Cardurion
Research and Development Cardurion is dedicated to advancing novel mechanisms to create new treatments for cardiovascular disease, which remains the most significant cause of …See details»
Our Science - Cardurion
Our Science We translate our world-class expertise in cardiovascular signaling pathways into groundbreaking therapeutics At Cardurion, we are advancing the understanding of signaling …See details»